Feedback
Settings

Settings

Goto Application

4,790,336 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

DS:GM

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 479,034
1.WO/2002/089216METHOD FOR INCREASING THE OUTPUT POWER OF PHOTOVOLTAIC CELLS
WO - 07.11.2002
Int.Class F24S 23/30
FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
24HEATING; RANGES; VENTILATING
SSOLAR HEAT COLLECTORS; SOLAR HEAT SYSTEMS
23Arrangements for concentrating solar rays for solar heat collectors
30with lenses
 Appl.No PCT/DZ2001/000004 Applicant HIHI, Bachir Inventor HIHI, Bachir
The invention concerns a method for increasing the output power of any photovoltaic cell using a linear concentration by means of a mutliprism and for using a special transparent film which can absorb up to 93 % of ultraviolet rays so that the temperature at the surface of the photovoltaic cells is acceptable.
2.WO/2003/048186SURFACE SIMULATION SYNTHETIC PEPTIDES USEFUL IN THE TREATMENT OF HYPER-VARIABLE VIRAL PATHOGENS
WO - 12.06.2003
Int.Class C07K 14/16
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
155Lentiviridae, e.g. human immunodeficiency virus , visna-maedi virus or equine infectious anaemia virus
16HIV-1
 Appl.No PCT/US2002/037664 Applicant CREVECOEUR, Harry Inventor CREVECOEUR, Harry
Synthetic peptides and methods for configuring the amino acid sequences thereof are disclosed which are especially useful in the preparation of vaccines intended for the prophylaxis and treatment of viral pathogens exhibiting high mutation rates such as HIV-1. The high mutation rates of such viral pathogens result in extreme variance in the linear sequence of viral protein residues, such as the variable linear sequences of gp 120 of HIV-1. To be effective and provide broad-spectrum and/or cross-clad coverage against hypervariable viruses such as HIV-1, vaccines must target common denominators of all infective strains of such a virus. These functional common denominators lie in the 3-dimensional configuration of proteins essential for host cell binding and infectivity. The disclosed peptides and methods for configuring same are derived from the 3 dimensional relationships of conserved residues of viral proteins defining conformational epitopes necessary and required for viral pathogenicity.
3.WO/2002/080938USE OF SODIUM NUCLEOSPERMATE FOR TREATING AIDS AND TREATMENT METHOD
WO - 17.10.2002
Int.Class A61K 31/7105
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7088Compounds having three or more nucleosides or nucleotides
7105Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
 Appl.No PCT/RU2002/000161 Applicant ASAFOV, Aleksandr Vilenovich Inventor ASAFOV, Aleksandr Vilenovich
The invention relates to medicine and can be used in order to develop medicinal agents (preparations) and treat AIDS. The aim of the invention is to improve the efficiency of the AIDS treatment by using the known sodium nucleospermate as a therapeutic agent, reducing toxicity of said therapeutic agent and extending the list of curing preparations used for treating AIDS, bearing in mind the combined use thereof. The inventive method consists in using the sodium nucleospermate as curing agent against AIDS or as an active principal of the therapeutic agent used for treating AIDS. Said sodium nucleospermate is also used for the inventive treatment method.
4.WO/1998/027144BIAXIALLY ORIENTED POLYPROPYLENE-BASE FILM
WO - 25.06.1998
Int.Class B29C 55/12
BPERFORMING OPERATIONS; TRANSPORTING
29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
55Shaping by stretching, e.g. drawing through a die; Apparatus therefor
02of plates or sheets
10multiaxial
12biaxial
 Appl.No PCT/JP1997/004641 Applicant CHISSO CORPORATION Inventor OKAYAMA, Chikashi
A biaxially oriented polypropylene-base film which is excellent in the straight cuttability in the machine direction, the strength in the transverse direction, and transparency and economically advantageous can be produced by biaxially stretching a film-forming material which comprises 40 to 88 wt. % of crystalline polypropylene and 60 to 12 wt. % of a propylene-α-olefin copolymer, the copolymer being dispersed in the crystalline polypropylene in the form of particles, in such a way as to give an oriented film wherein the dispersed particles of the copolymer have a mean particle diameter of 0.1 μm or below in the transverse direction.
5.WO/1998/051684ANTITHROMBOTIC COMPOUND
WO - 19.11.1998
Int.Class A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
38Medicinal preparations containing peptides
 Appl.No PCT/US1998/009311 Applicant ELI LILLY AND COMPANY Inventor JACKSON, Charles, Van
This application relates to a novel compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, processes and intermediates for its preparation, pharmaceutical formulations comprising the novel compound of formula (I), and the use of the compound of formula (I) as an antithrombotic agent.
6.WO/2000/001380cyclo-oxygenase inhibitor
WO - 13.01.2000
Int.Class A61K 31/41
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
 Appl.No PCT/DE1999/001100 Applicant A. NATTERMANN & CIE. GMBH Inventor TANAKA, Zyunji
The invention relates to a cyclo-oxygenase-2 inhibitor containing an active ingredient represented by the following formulas (1) and/or (1'), where R1 is a hydrogen atom or a C1-C3 alkyl group; R2 is a hydrogen atom, a hydroxyl group, an organic group suitable for binding within the molecule by its thioalcohol group; or R1 and R2 are linked such as to form a single bond; R3 is a hydrogen atom, a halogen atom, a C1-C3-alkyl group, a C1-C3-alkoxy group, a trifluoromethyl group or a nitro group; R4 and R5 can be identical or different and are a hydrogen atom, a halogen atom, a C1-C4-alkoxy group, a trifluoromethyl group; or R4 and R5 are linked together to form a methylenedioxy group or a salt or hydrate thereof.
7.WO/2000/042165BONE MARROW-SPECIFIC PROTEIN
WO - 20.07.2000
Int.Class A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
38Medicinal preparations containing peptides
 Appl.No PCT/US2000/000770 Applicant HUMAN GENOME SCIENCES, INC. Inventor DUAN, Roxanne, D.
The present invention relates to a novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, and/or preventing disorders related to this novel human protein.
8.WO/2000/026145CLARIFIER AND WATER PURIFICATION AND CLARIFICATION PLANT
WO - 11.05.2000
Int.Class C02F 1/52
CCHEMISTRY; METALLURGY
02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
1Treatment of water, waste water, or sewage
52by flocculation or precipitation of suspended impurities
 Appl.No PCT/RU1999/000331 Applicant FEDERALNOE GOSUDARSTVENNOE UNITARNOE PREDPRIYATIE 'ISSLEDOVATELSKY TSENTR IMENI M.V.KELDYSHA' Inventor BARANOV, Alexei Evgenievich
The present invention relates to a clarifier that comprises a body in the shape of a hollow cylinder having its lower end connected to a conical sludge compactor. The clarifier also includes units for feeding starting water and reactants as well as a unit for discharging the clarified water. The body includes a clarification chamber having a flocculation chamber arranged therein that further comprises a reaction chamber, said chambers being concentrically arranged. The clarification chamber is made in the shape of a truncated cone that widens towards the top. The flocculation chamber is made in the shape of a cylinder comprising a conical flare in its lower part as well as a plurality of baffles, wherein some baffles are arranged at the outlet of the flare while the others are regularly distributed on the inner surface of the chamber across the flow of purified water. In order to create a stable area of suspended sediments while maintaining a constant density, the clarification chamber and the sludge compactor are provided with ducts for separately discharging the purified water. This invention also relates to a water purification and clarification plant that comprises the following members connected in series: an aerator, two clarifiers comprising areas of suspended sediments and a sand filter. Each clarifier is fitted with ducts with units for supplying the reactants. The sediment discharge ducts from each clarifier are provided with pumps for feeding the sediments towards the filter (presses). The water discharge duct from the second clarifier towards the sand filter is also provided with a pump. The aerator consists of a water ejector comprising a supply pump, wherein the suction pipe of said pump is connected to the starting water duct into which gives a duct comprising a pump for withdrawing water from the suspended sediment area in the first clarifier.
9.WO/1998/056406STABLE INSULIN FORMULATIONS
WO - 17.12.1998
Int.Class A61K 38/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
28Insulins
 Appl.No PCT/US1998/012218 Applicant ELI LILLY AND COMPANY Inventor DEFELIPPIS, Michael, Rosario
The present invention provides a monomeric insulin analog formulation stabilized against aggregation in which the buffering agent is either TRIS or arginine. The stable formulations of the present invention are useful for treating diabetes, and are particularly advantageous in treatment regimes requiring lengthy chemical and physical stability, such as, in continuous infusion systems.
10.WO/1998/046580DEACYLATION PROCESS AND PRODUCT
WO - 22.10.1998
Int.Class C07K 9/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
9Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
 Appl.No PCT/US1998/007359 Applicant ELI LILLY AND COMPANY Inventor BRIGGS, Barbara, Shreve
The present invention is directed to deacyl teicoplanin, and to a process for preparing deacyl teicoplanin by reacting teicoplanin with ECB deacylase. Deacyl teicoplanin can be alkylated to produce compounds useful for their antibacterial activity.
# -